Boston Scientific (BSX) is a publicly traded Neuromodulation & Stimulation company founded in 1979 and based in Marlborough, United States.
No dated funding rounds on file. This company is privately held and may be raising or operating on undisclosed capital.
Directional, rechargeable DBS system for Parkinson's disease, essential tremor, and dystonia. Features multiple independent current control across segmented lead contacts, allowing physicians to steer stimulation fields precisely and minimize side effects. The Boston Scientific DBS programmer uses Adaptive DBS capabilities and integrates with the Bluetooth-enabled patient controller for self-managed therapy adjustments within physician-set parameters.
Spinal cord stimulation platform for chronic pain management featuring the ability to simultaneously deliver multiple waveform types — including sub-perception and paresthesia-based therapies — across independent therapy channels. Designed to personalize treatment via the SCS Navigation System, which uses proprietary AI to recommend stimulation programs. FDA-cleared; targets failed back surgery syndrome, complex regional pain syndrome, and peripheral neuropathy.
500 patents on file, but none with both an extractable figure and an abstract on Google Patents yet.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗